RARE Ultragenyx Pharmaceutical Inc. - Common Stock

NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗

$26,41

Fiyat · Ağu 19, 2026

Temel veriler itibarıyla Ağu 5, 2026

52 Haftlık Aralık

$18–$40

38% of range

Analist Derecelendirmesi

RARE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$26.41

Piyasa Değeri

$2.60B

P/E (TTM)

-4.6

EPS (TTM)

$-5.83

Gelir (TTM)

$673M

Temettü Verimi

—

ROE

-1613.2%

D/E Borç/Özsermaye

—

52 Haftlık Aralık

$18 – $40

RARE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $673M

2016-12-31 → 2025-12-31

Hisse Başına Kâr $-5.83

2020-12-31 → 2025-12-31

Serbest Nakit Akışı $-472M

2016-12-31 → 2025-12-31

Marjlar -85.4%

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

P/E (TTM)

-4.6

97.6

P/S (TTM) (F/S (TTM))

3.9

7.7

P/B (F/D)

-32.4

8.0

Price / FCF (Fiyat / Serbest Nakit Akışı)

-5.5

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

Operating Margin (Faaliyet Kâr Marjı)

-79.5%

—

Net Profit Margin (Net Kâr Marjı)

-85.4%

-51.7%

ROA

-37.9%

-44.2%

ROE

-1613.2%

-63.5%

ROIC

673.4%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

Current Ratio (Cari Oran)

2.5

4.9

Quick Ratio (Cari Oran)

1.5

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

20.2%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

22.8%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

20.0%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$-5.83

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

RARE

Akran Ortalaması

RARE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 25 analist

Güçlü Al 8 32,0%
Al 14 56,0%
Tut 3 12,0%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

19 analist · 2026-08-15

Medyan $46.00

Ortalama $52.84

← Tüm hedeflerin altında $26.41

Düşük $27.00

Yüksek $96.00

Medyan hedef $46.00 +74,2%

Ortalama hedef $52.84 +100,1%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

-0.08%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	$-0.90	$-1.24	0.34%
31 Mart 2026	$-1.84	$-1.54	-0.30%
31 Aralık 2025	$-1.29	$-1.11	-0.18%
30 Eylül 2025	$-1.81	$-1.26	-0.55%
30 Haziran 2025	$-1.17	$-1.32	0.15%
31 Mart 2025	$-1.57	$-1.65	0.08%

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	—
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	—
SLS	$577M	-15.1	—	—	-55.4%	—
KOD	$1.73B	-6.5	—	—	-202.0%	—
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	—
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	—
COAG	—	—	—	—	—	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 16

RARE için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Cost of Revenue	·	·	·	·	·	·	·	$1M	$1.0K	·
R&D Expense	$750M	$698M	$648M	$706M	$497M	$412M	$357M	$294M	$232M	$183M
SG&A Expense	$349M	$321M	$310M	$278M	$220M	$183M	$162M	$128M	$100M	$65M
Operating Expenses	·	·	·	·	·	$601M	$528M	$423M	$332M	$248M
Operating Income	$-535M	$-536M	$-569M	$-649M	$-382M	$-330M	$-424M	$-371M	$-329M	$-248M
Interest Income	$25M	$37M	$27M	$11M	$2M	$7M	$13M	$10M	$4M	$4M
Other Non-op	$1M	$-5M	$-1M	$-2M	$-2M	$607.0K	$-787.0K	$-6M	$7M	$-2M
Pretax Income	$-571M	$-567M	$-609M	$-702M	$-453M	$-185M	$-399M	$-197M	$-318M	$-246M
Income Tax	$4M	$2M	$-2M	$6M	$1M	$1M	$3M	$514.0K	$-16M	$35.0K
Net Income	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
EPS (Basic)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
EPS (Diluted)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
Shares (Basic)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
Shares (Diluted)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
EBITDA	$-500M	$-500M	$-543M	$-631M	$-368M	$-318M	$-416M	$-352M	$-323M	$-245M

Bilanço 29

RARE için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	$421M	$174M	$214M	$133M	$308M	$714M	$434M	$113M	$100M	$161M
Short-term Investments	·	·	·	·	·	·	$322M	$346M	$134M	$219M
Receivables	$158M	$122M	$73M	$40M	$28M	$23M	$33M	$13M	$5M	·
Inventory	$52M	$45M	$34M	$27M	$16M	$13M	$12M	$7M	$757.0K	·
Prepaid Expense	$61M	$40M	$48M	$69M	$72M	$58M	$51M	$43M	$29M	$20M
Other Current Assets	·	·	$48M	$69M	·	·	·	·	·	·
Current Assets	$951M	$817M	$732M	$884M	$857M	$1.30B	$851M	$522M	$270M	$402M
PP&E (Net)	$244M	$266M	$291M	$260M	$141M	$74M	$44M	$20M	$22M	$17M
PP&E (Gross)	$380M	$378M	$374M	$323M	$191M	$111M	$70M	$38M	$33M	$23M
Accum. Depreciation	$136M	$112M	$83M	$63M	$50M	$37M	$26M	$18M	$11M	$6M
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·
Intangibles	$176M	$178M	$166M	$160M	$131M	$131M	$129M	$129M	$142M	·
Other Non-current Assets	$60M	$63M	$58M	$48M	$21M	$9M	$3M	$4M	$3M	$2M
Total Assets	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Accounts Payable	$31M	$39M	$42M	$43M	$17M	$13M	$13M	$12M	$9M	$5M
Accrued Liabilities	$265M	$241M	$196M	$205M	$146M	$108M	$83M	$62M	$62M	$55M
Current Liabilities	$384M	$344M	$280M	$261M	$181M	$190M	$103M	$75M	$71M	$60M
Capital Leases	$24M	$30M	$31M	$20M	$30M	$39M	$30M	·	·	·
Deferred Tax	$30M	$30M	$30M	$32M	$33M	$33M	$33M	$31M	$31M	·
Other Non-current Liabilities	$44M	$17M	$12M	$5M	$1M	$7M	·	$5M	$5M	$6M
Total Liabilities	$1.60B	$1.24B	$1.22B	$1.19B	$600M	$605M	$482M	$111M	$107M	$67M
Common Stock	$0	$0	$82.0K	$70.0K	$69.0K	$67.0K	$58.0K	$51.0K	$44.0K	$41.0K
Paid-in Capital	$4.45B	$4.21B	$3.66B	$3.14B	$3.00B	$2.77B	$2.09B	$1.64B	$1.22B	$1.00B
Retained Earnings	$-4.53B	$-3.96B	$-3.39B	$-2.78B	$-2.07B	$-1.62B	$-1.43B	$-1.03B	$-833M	$-531M
Treasury Stock	$8M	$4M	$432.0K	$0	·	·	·	·	·	·
AOCI	$1M	$-1M	$647.0K	$-7M	$-1M	$689.0K	$-147.0K	$-633.0K	$-6M	$905.0K
Stockholders' Equity	$-80M	$255M	$275M	$352M	$923M	$1.15B	$654M	$609M	$383M	$474M
Liabilities + Equity	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Shares Outstanding	96,600,000	92,500,000	82,300,000	70,200,000	69,344,998	66,818,520	57,838,220	50,860,588	44,167,071	41,240,230

Nakit Akışı 13

RARE için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
D&A	$35M	$36M	$26M	$18M	$13M	$12M	$9M	$20M	$6M	$3M
Stock-based Comp	·	·	·	·	·	·	·	·	$68M	$48M
Deferred Tax	·	$-1M	$-2M	$2M	·	·	$2M	·	$-16M	·
Other Non-cash	$74M	$118M	$104M	$310M	$102M	$42M	$47M	$-112M	$-9M	$33M
Operating Cash Flow	$-466M	$-414M	$-475M	$-380M	$-339M	$-132M	$-345M	$-291M	$-254M	$-161M
CapEx	$6M	$7M	$44M	$116M	$73M	$44M	$25M	$4M	$3M	$10M
Investing Cash Flow	$236M	$-18M	$168M	$-292M	$-195M	$-179M	$-13M	$-33M	$55M	$91M
Stock Issued	·	·	·	$0	$0	$436M	$330M	$271M	·	·
Net Stock Activity	·	·	·	$0	·	$436M	$330M	$271M	·	·
Financing Cash Flow	$478M	$399M	$388M	$501M	$119M	$600M	$679M	$337M	$136M	$139M
Net Change in Cash	$252M	$-35M	$81M	$-172M	$-417M	$290M	$321M	$12M	$-62M	$69M
Taxes Paid	$4M	·	·	·	·	·	·	·	·	·
Free Cash Flow	$-472M	$-422M	$-519M	$-497M	$-412M	$-176M	$-370M	$-295M	$-257M	$-171M

Kârlılık 7

RARE için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Operating Margin	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%	-121.8%	-409.0%	-721.2%	-12593.5%	-186471.4%
Net Margin	-85.4%	-101.6%	-139.7%	-194.7%	-129.2%	-68.8%	-388.3%	-383.8%	-11567.3%	-184867.7%
Pretax Margin	-84.8%	-101.3%	-140.1%	-193.1%	-128.9%	-68.4%	-385.1%	-382.8%	-12187.5%	-184841.4%
EBITDA Margin	-74.3%	-89.3%	-125.1%	-173.6%	-104.9%	-117.3%	-400.8%	-683.2%	-12370.5%	-183897.0%
ROA	-37.9%	-38.0%	-40.0%	-46.1%	-27.7%	-12.9%	-43.4%	-32.6%	-58.6%	-44.7%
ROE	-1613.2%	-189.1%	-395.0%	-172.3%	-48.9%	-20.5%	-58.3%	-31.1%	-70.5%	-48.9%
ROIC	673.4%	-210.5%	-206.1%	-185.6%	-41.5%	-28.8%	-65.4%	-61.2%	-81.4%	-52.3%

Likidite ve Solventlik 2

RARE için Yıllık Likidite ve Solventlik verileri
Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Current Ratio		2.5	2.4	2.6	3.4	4.7	6.8	8.2	7.0	3.8	6.7
Quick Ratio		1.5	0.9	1.0	0.7	1.9	3.9	7.6	6.3	3.4	6.3

Verimlilik 3

RARE için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Asset Turnover	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0
Inventory Turnover	·	·	·	·	·	·	·	0.3	0.0	·
Receivables Turnover	4.8	5.7	7.6	10.6	13.6	9.7	4.6	5.7	1.0	·

Hisse Başına 5

RARE için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Book Value / Share	$-0.83	$2.76	$3.35	$5.02	$13.30	$17.28	$11.30	$11.97	$8.68	$11.49
Revenue / Share	$6.83	$6.19	$5.90	$5.20	·	·	·	·	·	·
Cash Flow / Share	$-4.73	$-4.57	$-6.46	$-5.44	·	·	·	·	·	·
Cash / Share	$4.36	$1.88	$2.59	$1.89	$4.44	$10.68	$7.50	$2.23	$2.28	$3.91
EPS (TTM)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	$-7.01	$-3.91	·	·

Büyüme Oranları 3

RARE için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue YoY	20.2%	29.0%	19.4%	3.4%	29.7%	·	·	·	·	·
Revenue CAGR 3Y	22.8%	16.8%	17.0%	·	·	·	·	·	·	·
Revenue CAGR 5Y	20.0%	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 10

RARE için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue TTM	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Net Income TTM	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
Market Cap	$2.22B	$3.89B	$3.94B	$3.25B	$5.83B	$9.25B	$2.47B	$2.21B	$2.05B	$2.90B
P/E	-3.9	-6.7	-5.8	-4.6	-12.6	-45.1	-6.1	-11.1	·	·
P/S	3.3	6.9	9.1	9.0	16.6	34.1	23.8	42.9	784.3	21801.5
P/B	-27.8	15.2	14.3	9.2	6.3	8.0	3.8	3.6	5.3	6.1
P / Tangible Book	·	117.9	61.2	22.1	7.8	9.4	·	·	·	·
P / Cash Flow	-4.8	-9.4	-8.3	-8.5	-17.2	-70.0	-7.2	-7.6	-8.1	-18.0
P / FCF	-4.7	-9.2	-7.6	-6.5	-14.2	-52.5	-6.7	-7.5	-8.0	-16.9
Earnings Yield	-25.4%	-14.9%	-17.2%	-21.8%	-8.0%	-2.2%	-16.4%	-9.0%	·	·

Gelir Tablosu 14

RARE için Çeyreklik Gelir Tablosu verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$214M	$136M	$207M	$160M	$167M	$139M	$165M	$139M	$147M	$109M	$127M	$98M	$108M	$100M	$103M	$91M
R&D Expense	$167M	$187M	$203M	$216M	$165M	$166M	$188M	$170M	$162M	$178M	$160M	$157M	$165M	$166M	$171M	$237M
SG&A Expense	$88M	$88M	$88M	$87M	$87M	$87M	$82M	$80M	$81M	$78M	$77M	$75M	$81M	$77M	$73M	$70M
Operating Income	$-75M	$-169M	$-113M	$-171M	$-108M	$-143M	$-122M	$-132M	$-116M	$-165M	$-122M	$-145M	$-148M	$-154M	$-146M	$-225M
Interest Income	$5M	$6M	$7M	$6M	$6M	$7M	$10M	$11M	$7M	$9M	$9M	$6M	$6M	$6M	$6M	$3M
Other Non-op	$1M	·	$-934.0K	$-1M	$2M	$837.0K	$-5M	$3M	$-2M	$-2M	$1M	$-699.0K	$-2M	$308.0K	$180.0K	$-1M
Pretax Income	$-91M	$-184M	$-128M	$-180M	$-114M	$-150M	$-133M	$-133M	$-131M	$-170M	$-127M	$-159M	$-159M	$-163M	$-153M	$-239M
Income Tax	$1M	$1M	$870.0K	$873.0K	$1M	$1M	$384.0K	$303.0K	$858.0K	$455.0K	$-4M	$650.0K	$732.0K	$495.0K	$-1M	$6M
Net Income	$-92M	$-185M	$-129M	$-180M	$-115M	$-151M	$-133M	$-134M	$-132M	$-171M	$-124M	$-160M	$-160M	$-164M	$-152M	$-245M
EPS (Basic)	$-0.90	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50
EPS (Diluted)	$-0.90	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50
Shares (Basic)	101,900,000	100,600,000	-195,920,392	99,771,297	98,500,000	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173
Shares (Diluted)	101,900,000	100,600,000	-195,920,392	99,771,297	98,500,000	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173
EBITDA	$-75M	$-161M	·	$-171M	$-108M	$-134M	·	$-132M	$-116M	$-157M	·	$-145M	$-148M	$-149M	·	$-225M

Bilanço 28

RARE için Çeyreklik Bilanço verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$125M	$175M	$421M	$203M	$176M	$127M	$174M	$151M	$481M	$112M	$214M	$73M	$102M	$86M	$133M	$392M
Receivables	$200M	$121M	$158M	$113M	$124M	$99M	$122M	$93M	$106M	$100M	·	$79M	$71M	$43M	·	$31M
Inventory	$59M	$55M	$52M	$52M	$46M	$46M	$45M	$43M	$40M	$36M	·	$32M	$28M	$27M	·	$22M
Prepaid Expense	$55M	$68M	$61M	$53M	$61M	$60M	$40M	·	·	·	·	$46M	$51M	$67M	·	$71M
Other Current Assets	·	·	·	·	·	·	·	$41M	$55M	$48M	·	·	·	·	·	·
Current Assets	$606M	$657M	$951M	$643M	$720M	$699M	$817M	$800M	$965M	$596M	·	$599M	$702M	$766M	·	$1.01B
PP&E (Net)	$235M	$239M	$244M	$250M	$256M	$261M	$266M	$272M	$279M	$285M	·	$297M	$289M	$278M	·	$235M
PP&E (Gross)	·	·	$380M	·	·	·	$378M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$136M	·	·	·	$112M	·	·	·	·	·	·	·	·	·
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·	$44M	$44M	$44M	·	$44M
Intangibles	$172M	$174M	$176M	$173M	$175M	$177M	$178M	$165M	$166M	$165M	·	$157M	$158M	$159M	·	$158M
Other Non-current Assets	$63M	$61M	$60M	$58M	$60M	$62M	$63M	$54M	$54M	$60M	·	$28M	$26M	$22M	·	$18M
Total Assets	$1.26B	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B
Accounts Payable	$39M	$42M	$31M	$41M	$34M	$47M	$39M	$36M	$60M	$41M	·	$33M	$42M	$59M	·	$24M
Accrued Liabilities	$221M	$194M	$265M	$221M	$181M	$173M	$241M	$185M	$154M	$149M	·	$179M	$168M	$144M	·	$189M
Current Liabilities	$351M	$325M	$384M	$340M	$293M	$292M	$344M	$285M	$273M	$246M	·	$254M	$244M	$218M	·	$227M
Capital Leases	·	·	$24M	$22M	$25M	$28M	$30M	·	·	·	·	·	·	·	·	·
Deferred Tax	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	·	$32M	$32M	$32M	·	$33M
Other Non-current Liabilities	$41M	$42M	$20M	$19M	$17M	$17M	$17M	$16M	$15M	$14M	·	$10M	$10M	$9M	·	$4M
Total Liabilities	$1.55B	$1.52B	$1.60B	$1.17B	$1.15B	$1.16B	$1.24B	$1.18B	$1.19B	$1.17B	·	$1.21B	$1.18B	$1.16B	·	$1.15B
Common Stock	$0	$0	$0	$96.0K	$96.0K	$94.0K	$0	$92.0K	$92.0K	$83.0K	·	$72.0K	$71.0K	$71.0K	·	$70.0K
Paid-in Capital	$4.52B	$4.48B	$4.45B	$4.41B	$4.37B	$4.25B	$4.21B	$4.17B	$4.12B	$3.70B	·	$3.30B	$3.24B	$3.17B	·	$3.11B
Retained Earnings	$-4.81B	$-4.72B	$-4.53B	$-4.40B	$-4.22B	$-4.11B	$-3.96B	$-3.82B	$-3.69B	$-3.56B	·	$-3.26B	$-3.10B	$-2.94B	·	$-2.63B
Treasury Stock	$10M	$10M	$8M	$8M	$8M	$8M	$4M	$4M	$3M	$3M	·	$381.0K	$381.0K	$356.0K	·	·
AOCI	$0	$0	$1M	$820.0K	$-268.0K	$-341.0K	$-1M	$896.0K	$-1M	$-431.0K	·	$-2M	$-3M	$-4M	·	$-10M
Stockholders' Equity	$-291M	$-236M	$-80M	$9M	$151M	$144M	$255M	$347M	$432M	$140M	$275M	$32M	$129M	$220M	$352M	$469M
Liabilities + Equity	$1.26B	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B
Shares Outstanding	98,600,000	98,300,000	96,600,000	96,442,027	96,353,634	93,903,785	92,500,000	92,304,317	92,135,384	83,094,037	82,300,000	72,174,307	71,465,424	70,660,249	70,197,297	70,079,777

Nakit Akışı 8

RARE için Çeyreklik Nakit Akışı verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$8M	$8M	$9M	$9M	$9M	$9M	$10M	$9M	$9M	$9M	$8M	$7M	$5M	$5M	$5M	$5M
Other Non-cash	·	$-20M	·	·	·	$-24M	·	·	·	$-29M	·	·	·	$2M	·	·
Operating Cash Flow	$-97M	$-197M	$-100M	$-91M	$-108M	$-166M	$-79M	$-67M	$-77M	$-191M	$-84M	$-118M	$-116M	$-157M	$-90M	$-95M
CapEx	$1M	$1M	$938.0K	$1M	$2M	$1M	$163.0K	$2M	$2M	$3M	$1M	$4M	$14M	$25M	$27M	$26M
Investing Cash Flow	$44M	$-49M	$-72M	$117M	$71M	$120M	$103M	$-276M	$61M	$94M	$-107M	$64M	$99M	$111M	$-172M	$-162M
Financing Cash Flow	·	·	$394M	$2.0K	$84M	$157.0K	$3M	$11M	$385M	$-58.0K	$330M	$25M	$33M	$-722.0K	$2M	$492M
Net Change in Cash	$-49M	$-247M	$221M	$26M	$49M	$-45M	$24M	$-330M	$368M	$-97M	$140M	$-29M	$16M	$-46M	$-259M	$234M
Free Cash Flow	·	$-198M	·	·	·	$-168M	·	·	·	$-194M	·	·	·	$-182M	·	·

Kârlılık 7

RARE için Çeyreklik Kârlılık verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-35.0%	-124.3%	·	-106.8%	-64.8%	-102.6%	·	-94.6%	-79.1%	-151.9%	·	-148.0%	-136.6%	-153.3%	·	-248.1%
Net Margin	-43.0%	-136.0%	·	-112.8%	-69.0%	-108.5%	·	-95.7%	-89.5%	-156.8%	·	-162.8%	-147.6%	-163.2%	·	-270.2%
Pretax Margin	-42.5%	-135.3%	·	-112.3%	-68.5%	-107.5%	·	-95.5%	-88.9%	-156.4%	·	-162.2%	-146.9%	-162.7%	·	-263.3%
EBITDA Margin	-35.0%	-118.4%	·	-106.8%	-64.8%	-96.2%	·	-94.6%	-79.1%	-143.8%	·	-148.0%	-136.6%	-148.1%	·	-248.1%
ROA	-7.2%	-14.2%	·	-13.2%	-7.9%	-11.5%	·	-9.6%	-9.0%	-12.7%	·	-11.2%	-12.2%	-11.8%	·	-15.8%
ROE	131.7%	403.2%	·	-101.4%	-39.4%	-106.2%	·	-70.5%	-46.9%	-94.6%	·	-63.8%	-39.6%	-32.2%	·	-34.9%
ROIC	26.1%	72.0%	·	-1874.9%	-71.9%	-100.0%	·	-38.1%	-27.1%	-118.2%	·	-459.4%	-115.2%	-70.1%	·	-49.3%

Likidite ve Solventlik 2

RARE için Çeyreklik Likidite ve Solventlik verileri
Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		1.7	2.0	·	1.9	2.5	2.4	·	2.8	3.5	2.4	·	2.4	2.9	3.5	·	4.5
Quick Ratio		0.9	0.9	·	0.9	1.0	0.8	·	0.9	2.1	0.9	·	0.6	0.7	0.6	·	1.9

Verimlilik 2

RARE için Çeyreklik Verimlilik verileri
Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.2	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Receivables Turnover		1.3	1.2	·	1.6	1.4	1.4	·	1.6	1.7	1.5	·	1.8	2.0	2.8	·	3.2

Hisse Başına 5

RARE için Çeyreklik Hisse Başına verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-2.95	$-2.40	·	$0.10	$1.57	$1.54	·	$3.76	$4.69	$1.69	·	$0.44	$1.81	$3.12	·	$6.69
Revenue / Share	$2.10	$1.35	·	$1.60	$1.69	$1.45	·	$1.46	$1.70	$1.29	·	$1.37	$1.53	$1.43	·	$1.29
Cash Flow / Share	·	$-1.96	·	·	·	$-1.73	·	·	·	$-2.26	·	·	·	$-2.23	·	·
Cash / Share	$1.27	$1.78	·	$2.10	$1.83	$1.35	·	$1.63	$5.22	$1.35	·	$1.01	$1.43	$1.21	·	$5.59
EPS (TTM)	$-5.72	$-6.39	·	$-5.95	$-5.66	$-6.52	·	$-7.18	$-8.03	$-8.84	·	$-10.31	$-10.34	$-10.28	·	$-9.03

Değerleme (TTM) 10

RARE için Çeyreklik Değerleme (TTM) verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$677M	$601M	·	$605M	$592M	$535M	·	$493M	$462M	$416M	·	$398M	$389M	$360M	·	$342M
Net Income TTM	$-572M	$-631M	·	$-580M	$-531M	$-587M	·	$-595M	$-622M	$-654M	·	$-729M	$-727M	$-720M	·	$-629M
Market Cap	$3.29B	$2.06B	·	$2.90B	$3.50B	$3.40B	·	$5.13B	$3.79B	$3.88B	·	$2.57B	$3.30B	$2.83B	·	$2.90B
P/E	-5.8	-3.3	·	-5.1	-6.4	-5.6	·	-7.7	-5.1	-5.3	·	-3.5	-4.5	-3.9	·	-4.6
P/S	4.9	3.4	·	4.8	5.9	6.4	·	10.4	8.2	9.3	·	6.5	8.5	7.9	·	8.5
P/B	-11.3	-8.7	·	316.7	23.2	23.6	·	14.8	8.8	27.7	·	81.1	25.5	12.9	·	6.2
P / Tangible Book	·	·	·	·	·	·	·	37.3	17.1	·	·	·	·	167.6	·	10.9
P / Cash Flow	·	-10.5	·	·	·	-20.4	·	·	·	-20.3	·	·	·	-18.1	·	·
P / FCF	·	-10.4	·	·	·	-20.3	·	·	·	-20.0	·	·	·	-15.6	·	·
Earnings Yield	-17.1%	-30.5%	·	-19.8%	-15.6%	-18.0%	·	-12.9%	-19.5%	-18.9%	·	-28.9%	-22.4%	-25.6%	·	-21.8%

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$673M	$560M	$434M	$363M	$351M
Faaliyet Kâr Marjı %	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%
Net Gelir	$-575M	$-569M	$-607M	$-707M	$-454M
Seyreltilmiş Hisse Başı Kâr	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	2.5	2.4	2.6	3.4	4.7
Cari Oran	1.5	0.9	1.0	0.7	1.9

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-472M	$-422M	$-519M	$-497M	$-412M

Son Haberler Bu şirketten bahseden son manşetler

Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks Yahoo Finance · 2 ay önce
FDA, Sanfilippo Sendromu Gen Terapisi UX111 İçin Ultragenyx'in (RARE) BLA'sını Kabul Etti Yahoo Finance · 4 ay önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kurumsal Sahipler (13F) 347 dosya · $2.7B toplam · Tarih itibarıyla 30 Haziran 2026

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
70 (+6 önceki Ç'ye göre)	37 (-8 önceki Ç'ye göre)	113 (-13 önceki Ç'ye göre)	97 (+10 önceki Ç'ye göre)	-486K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
RTW INVESTMENTS, LP	$260.338.324	7.796.895	9,48%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$226.722.608	6.790.135	8,26%	Hisse senetleri
STATE STREET CORP	$205.641.197	6.158.766	7,49%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$143.459.834	4.296.491	5,22%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$120.911.868	3.621.200	4,40%	Hisse senetleri
SANDS CAPITAL MANAGEMENT, LLC	$105.457.908	3.158.368	3,84%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$98.157.217	2.939.719	3,57%	Hisse senetleri
FRONTIER CAPITAL MANAGEMENT CO LLC	$95.092.590	2.847.936	3,46%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$73.869.758	2.211.828	2,69%	Hisse senetleri
Bellevue Group AG	$66.204.857	1.982.775	2,41%	Hisse senetleri
Sofinnova Investments, Inc.	$57.347.492	1.717.505	2,09%	Hisse senetleri
D. E. Shaw & Co., Inc.	$54.716.761	1.638.717	1,99%	Hisse senetleri
ADAGE CAPITAL PARTNERS GP, L.L.C.	$52.756.200	1.580.000	1,92%	Hisse senetleri
MPM BIOIMPACT LLC	$47.354.199	1.418.215	1,72%	Hisse senetleri
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$41.455.555	1.241.556	1,51%	Hisse senetleri
Candriam S.C.A.	$33.419.286	1.001.841	1,22%	Hisse senetleri
Rock Springs Capital Management LP	$32.316.678	967.855	1,18%	Hisse senetleri
Jefferies Financial Group Inc.	$31.040.212	929.626	1,13%	Hisse senetleri
Eagle Health Investments LP	$29.520.800	884.121	1,07%	Hisse senetleri
Qube Research & Technologies Ltd	$29.457.292	882.219	1,07%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$27.926.528	836.374	1,02%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$25.403.947	760.825	0,92%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$25.377.702	760.039	0,92%	Hisse senetleri
Caption Management, LLC	$24.000.732	718.800	0,87%	Satım opsiyonu
BANK OF AMERICA CORP /DE/	$23.505.893	703.980	0,86%	Hisse senetleri
Pictet Asset Management Holding SA	$23.159.948	753.695	0,84%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$22.418.413	671.411	0,82%	Hisse senetleri
GREAT POINT PARTNERS LLC	$20.034.000	600.000	0,73%	Satım opsiyonu
Palo Alto Investors LP	$19.916.968	596.495	0,73%	Hisse senetleri
SPHERA FUNDS MANAGEMENT LTD.	$19.649.815	588.494	0,72%	Hisse senetleri
PANAGORA ASSET MANAGEMENT INC	$19.574.220	586.230	0,71%	Hisse senetleri
Trexquant Investment LP	$18.577.695	556.385	0,68%	Hisse senetleri
BlackRock, Inc.	$18.510.448	554.371	0,67%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$16.995.510	509.000	0,62%	Satım opsiyonu
Sofinnova Investments, Inc.	$16.695.000	500.000	0,61%	Alım opsiyonu
BNP PARIBAS FINANCIAL MARKETS	$16.633.796	498.167	0,61%	Hisse senetleri
TORONTO DOMINION BANK	$13.856.850	415.000	0,50%	Hisse senetleri
VANGUARD GROUP INC	$13.818.814	600.818	0,50%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$13.813.443	413.700	0,50%	Hisse senetleri
Caption Management, LLC	$13.753.341	411.900	0,50%	Alım opsiyonu
Cutter Capital Management, LP	$13.734.562	379.303	0,50%	Hisse senetleri
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$13.624.489	408.041	0,50%	Hisse senetleri
ALGERT GLOBAL LLC	$13.020.898	389.964	0,47%	Hisse senetleri
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$12.735.614	381.420	0,46%	Hisse senetleri
AXA Investment Managers S.A.	$12.549.316	417.198	0,46%	Hisse senetleri
SummitTX Capital, L.P.	$12.496.875	374.270	0,46%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$12.394.401	371.201	0,45%	Hisse senetleri
Privium Fund Management B.V.	$11.312.532	338.800	0,41%	Hisse senetleri
Squarepoint Ops LLC	$11.298.108	338.368	0,41%	Hisse senetleri
Walleye Capital LLC	$11.180.775	334.854	0,41%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$11.076.800	481.600	0,40%	Hisse senetleri
Catalio Capital Management, LP	$10.559.654	316.252	0,38%	Hisse senetleri
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$9.944.000	297.819	0,36%	Hisse senetleri
Ensign Peak Advisors, Inc	$9.710.413	290.818	0,35%	Hisse senetleri
GordonMD Global Investments LP	$9.653.082	289.101	0,35%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$9.215.640	276.000	0,34%	Alım opsiyonu
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$8.929.454	267.429	0,33%	Hisse senetleri
FMR LLC	$8.597.725	257.494	0,31%	Hisse senetleri
Quantinno Capital Management LP	$8.363.060	250.466	0,30%	Hisse senetleri
JPMORGAN CHASE & CO	$7.279.842	232.755	0,27%	Hisse senetleri
KENNEDY CAPITAL MANAGEMENT LLC	$7.212.140	215.997	0,26%	Hisse senetleri
WORLDQUANT MILLENNIUM ADVISORS LLC	$7.157.948	214.374	0,26%	Hisse senetleri
CITADEL ADVISORS LLC	$7.029.630	210.531	0,26%	Hisse senetleri
Ishara Investments LP	$6.844.950	205.000	0,25%	Hisse senetleri
Man Group plc	$6.508.245	194.916	0,24%	Hisse senetleri
FIFTH THIRD BANCORP	$6.452.150	193.236	0,23%	Hisse senetleri
Connor, Clark & Lunn Investment Management Ltd.	$6.396.789	191.578	0,23%	Hisse senetleri
Blue Owl Capital Holdings LP	$6.098.283	182.638	0,22%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$6.039.283	180.871	0,22%	Hisse senetleri
Woodline Partners LP	$5.736.569	171.805	0,21%	Hisse senetleri
Atom Investors LP	$5.735.434	171.771	0,21%	Hisse senetleri
Swiss National Bank	$5.597.900	167.652	0,20%	Hisse senetleri
Ikarian Capital, LLC	$5.529.952	165.617	0,20%	Hisse senetleri
Stonepine Capital Management, LLC	$5.500.000	200.000	0,20%	Alım opsiyonu
SCHRODER INVESTMENT MANAGEMENT GROUP	$5.260.270	171.456	0,19%	Hisse senetleri
BOOTHBAY FUND MANAGEMENT, LLC	$5.229.275	156.612	0,19%	Hisse senetleri
Cubist Systematic Strategies, LLC	$5.194.035	172.674	0,19%	Hisse senetleri
Eversept Partners, LP	$5.146.401	154.130	0,19%	Hisse senetleri
MARSHALL WACE, LLP	$5.053.810	151.357	0,18%	Hisse senetleri
Ghisallo Capital Management LLC	$5.008.500	150.000	0,18%	Hisse senetleri
Mariner, LLC	$4.887.301	146.400	0,18%	Hisse senetleri
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$4.841.550	145.000	0,18%	Hisse senetleri
FRED ALGER MANAGEMENT, LLC	$4.779.945	143.155	0,17%	Hisse senetleri
Corient Private Wealth LP	$4.644.350	139.094	0,17%	Hisse senetleri
SR One Capital Management, LP	$4.599.573	137.753	0,17%	Hisse senetleri
B Group, Inc.	$4.507.650	135.000	0,16%	Hisse senetleri
PINNACLE ASSOCIATES LTD	$4.377.563	131.104	0,16%	Hisse senetleri
Caption Management, LLC	$4.340.700	130.000	0,16%	Hisse senetleri
MOORE CAPITAL MANAGEMENT, LP	$4.275.089	128.035	0,16%	Hisse senetleri
RHUMBLINE ADVISERS	$4.144.518	124.125	0,15%	Hisse senetleri
Apollon Wealth Management, LLC	$4.121.962	123.449	0,15%	Hisse senetleri
Odyssean, LLC	$4.076.485	122.087	0,15%	Hisse senetleri
Assenagon Asset Management S.A.	$4.035.649	120.864	0,15%	Hisse senetleri
EFG Asset Management (North America) Corp.	$3.848.509	127.985	0,14%	Hisse senetleri
BARCLAYS PLC	$3.742.919	112.097	0,14%	Hisse senetleri
IEQ CAPITAL, LLC	$3.540.194	106.026	0,13%	Hisse senetleri
Rafferty Asset Management, LLC	$3.394.260	101.655	0,12%	Hisse senetleri
Crestwood Advisors Group, LLC	$3.348.149	100.274	0,12%	Hisse senetleri
Tetragon Partners GP Ltd	$3.339.000	100.000	0,12%	Alım opsiyonu
CITADEL ADVISORS LLC	$3.308.949	99.100	0,12%	Satım opsiyonu

Şirket yöneticileri 28 içeriden öğrenenler · 15 yöneticiler · 11 yönetim kurulu üyeleri

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Emil D Kakkis	President & CEO	16 Nisan 2026 A	735.739	1	$-1.240.411
Howard Horn	Chief Financial Officer	03 Ağustos 2026 S	96.295	12	$-1.332.021
Mardi Dier	CFO & Executive Vice President	14 Ekim 2022 S	66.695	0	$0
Wladimir Hogenhuis	Chief Operating Officer	04 Ekim 2019 F	18.703	0	$0
Karah Herdman Parschauer	EVP and Chief Legal Officer	03 Ağustos 2026 S	92.562	5	$-487.890
Eric Crombez	EVP and Chief Medical Officer	05 Mayıs 2026 S	111.189	2	$-168.847
Theodore Alan Huizenga	SVP, Chief Accounting Officer	22 Nisan 2026 A	68.911	4	$-44.636
Erik Harris	EVP & Chief Commercial Officer	16 Nisan 2026 A	118.410	1	$-240.289
John Richard Pinion	EVP, Chief Quality Operations Officer	16 Nisan 2026 A	133.142	1	$-228.661
Dennis Karl Huang	EVP, Chief Technical Operations Officer	16 Nisan 2026 A	147.845	0	$0
Thomas Richard Kassberg	CBO & EVP	03 Mart 2025 F	264.730	0	$0
Camille L Bedrosian	EVP and Chief Medical Officer	01 Mart 2023 S	46.720	0	$0
Shalini Sharp	EVP, Finance	14 Ekim 2020 S	97.812	0	$0
Jayson Donald Alexander Dallas	EVP & Chief Commercial Officer	01 Haziran 2018 F	23.830	0	$0
Sunil Agarwal	Chief Medical Officer	21 Mayıs 2015 A	29.400	0	$0
Corazon (Corsee) D. Sanders	Yönetim kurulu üyesi	15 Haziran 2026 S	21.095	1	$-50.100
Deborah Dunsire	Yönetim kurulu üyesi	14 Mayıs 2026 A	38.566	0	$0
Daniel G Welch	Yönetim kurulu üyesi	14 Mayıs 2026 A	40.441	0	$0
Amrit Ray	Yönetim kurulu üyesi	15 Mayıs 2025 A	23.365	0	$0
Shehnaaz Suliman	Yönetim kurulu üyesi	15 Mayıs 2025 A	25.940	0	$0
Lars Ekman	Yönetim kurulu üyesi	24 Haziran 2022 A	17.745	0	$0
William Aliski	Yönetim kurulu üyesi	24 Haziran 2021 A	66.849	0	$0
Clay B Siegall	Yönetim kurulu üyesi	10 Ağustos 2020 M	2.550	0	$0
Eran Nadav	Yönetim kurulu üyesi	10 Temmuz 2014 A	—	0	$0
Marten Steen	Yönetim kurulu üyesi	30 Ocak 2014 A	—	0	$0
Matthew K Fust	—	14 Mayıs 2026 A	33.696	0	$0
Michael Narachi	—	14 Mayıs 2026 A	40.441	0	$0
FMR LLC	—	01 Ağustos 2014 J	1.457.994	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

Aktivistler ve %5+ sahipler 1 pozisyon

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Ultragenyx Pharmaceutical Inc.	06 Kasım 2020	—	İlk başvuru	Pasif yatırım	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF sahipliği 48 ETF'ler tarafından tutuluyor

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
TMFS · RBB Fund, Inc.	3,03%	74.931 NS	31 Mayıs 2026	N-PORT
GNOM · Global X Funds	2,25%	52.426 NS	31 Mayıs 2026	N-PORT
HAPS · Harbor ETF Trust	1,31%	83.707 NS	30 Nisan 2026	N-PORT
BBP · ETFis Series Trust I	1,09%	26.120 NS	30 Nisan 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,85%	178.057 NS	30 Nisan 2026	N-PORT
MMLG · First Trust Exchange-Traded Fund VI…	0,36%	13.877 NS	31 Mayıs 2026	N-PORT
ESSC · Strategy Shares	0,31%	3.204 NS	30 Nisan 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,13%	54.688 NS	30 Nisan 2026	N-PORT
BIB · ProShares Trust	0,12%	3.571 NS	31 Mayıs 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,12%	34.325 NS	30 Nisan 2026	N-PORT
GINN · Goldman Sachs ETF Trust	0,11%	9.780 NS	31 Mayıs 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,10%	3.381 NS	30 Nisan 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,05%	463.045 NS	31 Mayıs 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,03%	39.736 NS	30 Nisan 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,03%	5.097 NS	30 Nisan 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	3.648 NS	31 Mayıs 2026	N-PORT
GGUS · Goldman Sachs ETF Trust	0,01%	1.628 NS	31 Mayıs 2026	N-PORT
ONEQ · Fidelity Commonwealth Trust	0,01%	32.531 NS	31 Mayıs 2026	N-PORT
TILT · FlexShares Trust	0,00%	3.080 NS	30 Nisan 2026	N-PORT
JUST · Goldman Sachs ETF Trust	0,00%	859 NS	31 Mayıs 2026	N-PORT
RECS · Columbia ETF Trust I	0,00%	7.427 NS	30 Nisan 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0,00%	56.898 NS	31 Mayıs 2026	N-PORT
MSLC · MORGAN STANLEY PATHWAY FUNDS	0,00%	3.007 NS	31 Mayıs 2026	N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST	0,00%	129 NS	31 Mayıs 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	—	—	15 Temmuz 2026	Günlük
VB · VANGUARD INDEX FUNDS	—	—	15 Temmuz 2026	Günlük
VBK · VANGUARD INDEX FUNDS	—	—	15 Temmuz 2026	Günlük
VTI · VANGUARD INDEX FUNDS	—	—	15 Temmuz 2026	Günlük
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	—	—	15 Temmuz 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	—	—	15 Temmuz 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	—	—	15 Temmuz 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	—	—	15 Temmuz 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	—	—	15 Temmuz 2026	Günlük
ITOT · iShares Trust	—	—	05 Ağustos 2026	Günlük
IWV · iShares Trust	—	—	18 Ağustos 2026	Günlük
IWN · iShares Trust	—	—	17 Ağustos 2026	Günlük
IWO · iShares Trust	—	—	18 Ağustos 2026	Günlük
IWM · iShares Trust	—	—	18 Ağustos 2026	Günlük
IBB · iShares Trust	—	—	18 Ağustos 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	—	—	28 Temmuz 2026	Günlük
VHT · VANGUARD WORLD FUND	—	—	20 Temmuz 2026	Günlük
ESGV · VANGUARD WORLD FUND	—	—	30 Temmuz 2026	Günlük
ISCB · iShares Trust	—	—	05 Ağustos 2026	Günlük
ISCG · iShares Trust	—	—	05 Ağustos 2026	Günlük
ISCV · iShares Trust	—	—	05 Ağustos 2026	Günlük
ESML · iShares Trust	—	—	14 Ağustos 2026	Günlük
WSML · iShares Trust	—	—	05 Ağustos 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	—	—	20 Temmuz 2026	Günlük

RARE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

RARE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

RARE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

Kurumsal Sahipler (13F) 347 dosya · $2.7B toplam · Tarih itibarıyla 30 Haziran 2026

Şirket yöneticileri 28 içeriden öğrenenler · 15 yöneticiler · 11 yönetim kurulu üyeleri

Aktivistler ve %5+ sahipler 1 pozisyon

ETF sahipliği 48 ETF'ler tarafından tutuluyor